The DMRTA2 gene helps guide early brain development, especially the growth and layout of the cerebral cortex, the brain’s outer thinking layer. This gene plays an important role in helping brain cells develop in the right places before birth. When both copies of the gene do not work properly, a child may be born with a much smaller head size and differences in brain structure, often along with developmental delay. The DMRTA2 gene is mainly known in rare genetic conditions and has not become a widely discussed public gene.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or manage processes in the body. Some genes hold the information needed to produce proteins, which are the working parts of cells. Others mainly help determine when certain processes happen, where they happen, and how strongly they operate. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can find more in the LearnHub.
Overview
DMRTA2Gene function
What if the gene works
The DMRTA2 gene helps switch other genes on and off during early development, especially in the brain and eyes. It supports normal growth and patterning of parts of the forebrain.
Risk
What if the gene does not work
If the DMRTA2 gene does not work properly, brain development may be disrupted, often leading to small head size, a smoother brain surface, and developmental delay. Milder or more severe variants can affect timing and severity.
Treatment
What does that mean for your treatment
No treatment or drug choice approach specific to the DMRTA2 gene is currently established for people with a pathogenic or loss-of-function variant in the DMRTA2 gene.
Gene function
What if the gene works
The DMRTA2 gene helps direct some of the earliest steps of brain development before birth. It is most active in the front part of the developing brain, where cells need clear timing and position signals. By controlling other genes, it supports orderly growth of brain tissue and formation of the brain's outer layer.
The DMRTA2 gene acts like a genetic switch, turning groups of other genes on or off during development. This helps young brain cells follow the right instructions at the right time.
This gene helps map out parts of the front of the developing brain so nearby cells take on the right regional roles. That is a key part of the role of the DMRTA2 gene in brain development and helps tissue form in an organized way.
DMRTA2 helps keep a healthy balance between cells that keep dividing and cells that start becoming nerve cells. This supports steady growth while still allowing the brain to build specialized cells.
It supports formation of the brain's outer layer, which is important for thinking, movement, and sensing the world. It helps this layer grow with orderly structure as new cells are added.
What is a variant?
A gene variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
DMRTA2 gene variants can weaken or shut down the protein’s ability to bind DNA and control other genes in early brain cells, which is central to how DMRTA2 gene variants affect brain development. Milder variants may leave some activity, while more severe variants, including changes that shorten the protein or alter its DNA binding region, can greatly reduce its stability or activity. In conditions linked to the DMRTA2 gene, this functional range often relates to how early features appear and how pronounced they are.
How variants are linked to conditions
Pathogenic variants in the DMRTA2 gene are linked to a rare inherited condition with congenital microcephaly and major changes in brain development. Reported features include a smooth or simplified brain surface and other structural brain differences that may be seen on scans. Many affected children also have developmental delay, seizures, or vision problems. This is a rare genetic diagnosis, not a common risk variant.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to DMRTA2. People with concerns about their personal or family risk can discuss it with a doctor or genetic counselor.
Inheritance of DMRTA2 variants
Information on how DMRTA2 gene variants are inherited is most consistent with an autosomal recessive pattern. This means a child usually inherits one changed copy of the DMRTA2 gene from each parent. Parents who carry one changed copy are often unaffected, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is also a carrier, and a 25% chance of having a child who inherits neither changed copy. Because the DMRTA2 gene is on an autosome, this pattern is the same for boys and girls.
What does my DMRTA2 result mean for my family?
For families with a disease-causing DMRTA2 result linked to a recognized condition, the pattern is thought to be recessive, which means close relatives may also be carriers even if they are healthy. Brothers or sisters could also be affected or be carriers, and other relatives may want to learn whether the variant runs in the family. This can be especially relevant when planning a pregnancy.
Genetic information
Genetic testing
How you find out about variants
DMRTA2 genetic testing usually uses a blood or saliva sample to read the DMRTA2 gene and look for variants. It is often done as part of a broader panel or exome test when a person has brain development findings. Results may show a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Testing for DMRTA2 may be considered when a baby or child has a very small head size, major delays in development, or brain differences seen on imaging that suggest a rare inherited condition. It can also be useful when there is a family history of similar findings or a previous child with the same pattern.
A genetic result is only one part of your health story
Genetic results can provide valuable insight, but what they can tell you varies with the condition and the specific type of variant involved. How the body functions over time is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, these results can help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more quickly, while another may process it more slowly or be more sensitive to its effects. This is a common reason the same treatment can work better for some people than for others, or cause different side effects.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how differences in genes affect the way people respond to medications. It examines links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can influence how powerfully a drug works or how the body handles it. This information can help guide more informed, personalized treatment decisions. To explore this subject further, you can learn more in the LearnHub.
Drugs influenced by the DMRTA2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so questions about symptoms, general health, or medication side effects are best discussed with your doctor.
History
In recent decades, awareness of the DMRTA2 gene’s role has grown through research on early brain development. It was identified as part of the DMRT family, a group of genes named for similarities to genes first studied in animals. Early work placed DMRTA2 among genes active during embryo development, especially in forming the forebrain. From these first observations, research expanded steadily, and scientists later connected changes in this gene with rare conditions affecting brain growth and structure. As genetic testing became more widely used, DMRTA2 moved from a research finding to a gene recognized in clinical genetics. Its history is mainly one of careful laboratory discovery rather than public attention, with knowledge building step by step from developmental biology to patient diagnosis.